https://www.selleckchem.com/pr....oducts/idf-11774.htm
INTRODUCTION Extended half-life factor IX concentrates (EHL-FIX) can be administered weekly to prevent bleeding for persons with severe haemophilia B. We report the experience of a large UK haemophilia comprehensive care centre using low dose EHL-FIX for persons with severe haemophilia B. AIM The low doses used in real world are approximately half of the doses used in clinical trials. We aim to assess the efficacy and safety of low dose EHL-FIX. METHODS Data from a cohort of 13 patients who were switched from standard half-life factor
Like
Comment
Share
